@article{WuStoddartWuertzKozaketal.2017,
  author    = {Wu, Yabin and Stoddart, Martin J. and Wuertz-Kozak, Karin and Grad, Sibylle and Alini, Mauro and Ferguson, Stephen J.},
  title     = {Hyaluronan supplementation as a mechanical regulator of cartilage tissue development under joint-kinematic-mimicking loading},
  series = {Interface : journal of the Royal Society},
  volume    = {14},
  journal   = {Interface : journal of the Royal Society},
  publisher = {Royal Society},
  address   = {London},
  issn      = {1742-5689},
  doi       = {10.1098/rsif.2017.0255},
  pages     = {9},
  year      = {2017},
  language  = {en}
}
@article{ShahidManchiSlunskyetal.2017,
  author    = {Shahid, Muhammad and Manchi, G. and Slunsky, Pavel and Naseer, O. and Fatima, A. and Leo, B. and Raila, Jens},
  title     = {A systemic review of existing serological possibilities to diagnose canine osteoarthritis with a particular focus on extracellular matrix proteoglycans and protein},
  series = {Polish journal of veterinary sciences : PJVS : the journal of Committee of Veterinary Sciences of Polish Academy of Sciences and University of Warmia and Mazury in Olsztyn},
  volume    = {20},
  journal   = {Polish journal of veterinary sciences : PJVS : the journal of Committee of Veterinary Sciences of Polish Academy of Sciences and University of Warmia and Mazury in Olsztyn},
  number    = {1},
  publisher = {De Gruyter},
  address   = {Berlin},
  issn      = {1505-1773},
  doi       = {10.1515/pjvs-2017-0024},
  pages     = {189 -- 201},
  year      = {2017},
  abstract  = {Extra-cellular matrix (ECM) components are important and their stabilization is significant in maintaining normal healthy joint environment. In osteoarthritis (OA), ECM components are altered and indicate disease progression. The joint ECM is composed of proteoglycans (aggrecan, perlecan,inter α-trypsin inhibitor), glycoproteins (fibronectin, lubricin, COMP) and collagen types (most abundantly collagen type II) which represent structural and functional transformation during disease advancement. ECM investigation revealed significant biomarkers of OA that could be used as a diagnostic and therapeutic tool in different canine orthopedic diseases. This review deliberates our current findings of how the components of ECM change at the molecular level during disease progression in canine OA.},
  language  = {en}
}